Browse 127 Cirrhosis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Cirrhosis is a late-stage liver disease in which the liver becomes severely scarred due to prolonged liver damage from causes like hepatitis, alcohol abuse, or fatty liver disease.
Clinical trials for cirrhosis explore innovative treatments aimed at slowing liver damage and improving liver function, offering participants access to the latest therapies designed to help manage their condition and improve liver health.
Location: North Dartmouth MA, Boston MA, Stony Brook NY,
Sponsor: United Therapeutics
Sex: All
Age: 18+
Code: NCT05943535
Phase3, Recruiting
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
for
Metabolic Dysfunction-associated Steatohepatitis
Location: Miami FL, Ocala FL, St Louis MO, Little Rock AR,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07701993
Phase3, Recruiting
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
for
Metabolic Dysfunction-associated Steatohepatitis
Location: New York NY, Morehead City NC, Miami FL, Ocala FL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07704892
Phase3, Recruiting
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
for
Metabolic Dysfunction-Associated Steatohepatitis,
Location: New York NY, Baltimore MD, Marietta GA, Richmond VA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT06920043
Phase2, Recruiting
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis